An epidemiological survey covering 100,000 people showed that among adults aged 18 and above, 30.6% were overweight and 12% were obese. The prevalence of obesity was positively correlated with economic development.In the past, the medical community divided obesity into two categories: simple obesity and pathological obesity. With deeper understanding, obesity can now be classified into […]
Tag: Obesity
Core Mechanisms of Obesity or Metabolic Abnormalities Leading to Cardiovascular Disease (CVD)
The essence of obesity is the accumulation of abnormal adipose tissue, often accompanied by ectopic fat deposition in the liver, arterial walls, epicardium, and other sites. Such ectopic deposition significantly increases the risk of CVD, including atherosclerosis-induced hypertension, dyslipidemia, and a prediabetic state. Visceral fat deposition also impairs the function of other organs, such as […]
Improved Assessment of Obesity-Related Health Risks in Cardiovascular Diseases
With a deeper understanding of the harms of obesity and its association with cardiovascular disease (CVD), a relatively systematic scientific consensus has been formed in the academic community. Against this background, the Chinese Cardiometabolic Alliance organized multidisciplinary experts to formulate and issue the Expert Consensus on Weight Management in Patients with Cardiovascular Disease (2025) (hereinafter […]
Professor Andreas Liebl, Diabetes and Metabolism Center Bad Heilbrunn, Germany:Populations for Whom Weight Loss‑Centered Treatment Strategies Should Be Prioritized
Obesity has been recognized as one of the core therapeutic targets in type 2 diabetes mellitus (T2DM).Professor Andreas Liebl emphasizes that weight control itself is an independent therapeutic goal.However, given limited medical resources, it is essential to define priority populations.In his view, the following patient groups should receive prioritized intervention:First group: Early‑stage diabetes patients with […]
Professor Andreas Liebl (Diabetes and Metabolism Center Bad Heilbrunn, Germany): Reshaping the Future Landscape of T2DM and Obesity Management
Professor Andreas Liebl from the Diabetes and Metabolism Center Bad Heilbrunn, Germany, believes that the iteration and upgrading of innovative drugs will be most critical in the coming years. Drugs targeting GLP‑1, GIP, and glucagon receptors will be continuously optimized and diversified. As I noted earlier, such agents allow us to manage patients from a […]
Metabolic Surgery Achieves Better Glycemic Control and Reduced Cardiovascular Risk in Patients with Type 2 Diabetes and Obesity
Bariatric surgery for obesity promotes significant and sustained weight loss, and improves glycemic control and long-term outcomes in patients with type 2 diabetes. Given the magnitude and speed of improvement in hyperglycemia and glucose homeostasis, these procedures have even been proposed for the treatment of type 2 diabetes in individuals without severe obesity, so the […]
Obesity can trigger diabetes
The Lancet Diabetes & Endocrinology has published the key findings of the 11th edition of the International Diabetes Federation (IDF) Diabetes Atlas, which reveals the latest global diabetes prevalence data for 2024 and trend projections for 2050. A fundamental aspect of the study is that the IDF used an “epidemiological definition” based on a single […]